Catalent Pharma Solutions is expanding its potent handling and manufacturing capabilities at its facility in Somerset, New Jersey.

The company has completed the expansion of facility and engineering controls for its high-potency tableting and OptiMelt Hot Melt Extrusion operations in Somerset to supplement existing potent capabilities in oral solid and its Zydis Fast Dissolve manufacturing. The company is now investing in additional potent containment for large-scale blending, fluid-bed processing, and high-shear granulation, which will come on line throughout the first half of 2015.

The Somerset facility is capable of handling SafeBridge Category 3 and 4, with SafeBridge certification expected in July of 2015.

The expansion creates a manufacturing Center of Excellence for potent handling across Catalent's portfolio of oral solid manufacturing solutions, which includes hot-melt extrusion, high-shear and wet granulation processing, solvent-based capability, extrusion/spheronization, fluid-bed processing, Wurster coating, and compression and encapsulation. The company also recently announced investments in high-potency clinical packaging and acquired Micron Technologies, a provider of particle-size engineering technologies.

Source: Catalent Pharma Solutions